Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil K Rustgi

Showing results (181-190 of 327) with videos related to

Pageof 33
Sort By:
Contemporary Clinical Trials|March 13, 2016
A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment resultsJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Clinical Colorectal Cancer|July 4, 2017
Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II TrialJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Endocrine-Related Cancer|October 12, 2017
Dose-response effects of exercise on insulin among colon cancer survivorsJustin C Brown, Michael R Rickels, Andrea B Troxel, et al.
British Journal of Cancer|September 22, 2017
Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trialJustin C Brown, Babette S Zemel, Andrea B Troxel, et al.
Gastroenterology|November 20, 2012
Advances in acute and chronic pancreatitis: from development to inflammation and repairMarina Pasca di Magliano, Christopher Forsmark, Steven Freedman, et al.
Nature Communications|March 23, 2019
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinomaShuo Qie, Akihiro Yoshida, Stuart Parnham, et al.
Molecular and Cellular Biology|November 14, 2007
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylationCameron N Johnstone, Perry S Mongroo, A Sophie Rich, et al.
Genes & Development|January 17, 2016
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonizationShigetsugu Takano, Maximilian Reichert, Basil Bakir, et al.
Psycho-Oncology|February 2, 2018
A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivorsJustin C Brown, Nevena Damjanov, Kerry S Courneya, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
The mitochondrial Ca <sup>2+</sup> channel MCU is critical for tumor growth by supporting cell cycle progression and proliferationEmily Fernández García, Usha Paudel, Michael C Noji, et al.
Pageof 33

Showing results (181-190 of 327) with videos related to

Sort By:
Pageof 33
Contemporary Clinical Trials|March 13, 2016
A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment resultsJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Clinical Colorectal Cancer|July 4, 2017
Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II TrialJustin C Brown, Andrea B Troxel, Bonnie Ky, et al.
Endocrine-Related Cancer|October 12, 2017
Dose-response effects of exercise on insulin among colon cancer survivorsJustin C Brown, Michael R Rickels, Andrea B Troxel, et al.
British Journal of Cancer|September 22, 2017
Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trialJustin C Brown, Babette S Zemel, Andrea B Troxel, et al.
Gastroenterology|November 20, 2012
Advances in acute and chronic pancreatitis: from development to inflammation and repairMarina Pasca di Magliano, Christopher Forsmark, Steven Freedman, et al.
Nature Communications|March 23, 2019
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinomaShuo Qie, Akihiro Yoshida, Stuart Parnham, et al.
Molecular and Cellular Biology|November 14, 2007
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylationCameron N Johnstone, Perry S Mongroo, A Sophie Rich, et al.
Genes & Development|January 17, 2016
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonizationShigetsugu Takano, Maximilian Reichert, Basil Bakir, et al.
Psycho-Oncology|February 2, 2018
A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivorsJustin C Brown, Nevena Damjanov, Kerry S Courneya, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
The mitochondrial Ca <sup>2+</sup> channel MCU is critical for tumor growth by supporting cell cycle progression and proliferationEmily Fernández García, Usha Paudel, Michael C Noji, et al.
Pageof 33